REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 149 filers reported holding REATA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $418 | -99.9% | 11 | -100.0% | 0.00% | -100.0% |
| Q3 2022 | $767,000 | -73.9% | 30,518 | -68.4% | 0.00% | -80.0% |
| Q2 2022 | $2,935,000 | +881.6% | 96,598 | +959.5% | 0.01% | +900.0% |
| Q1 2022 | $299,000 | -92.2% | 9,117 | -93.7% | 0.00% | -92.3% |
| Q4 2021 | $3,811,000 | -82.7% | 144,521 | -34.6% | 0.01% | -88.0% |
| Q1 2021 | $22,044,000 | +200.6% | 221,109 | +193.7% | 0.11% | +100.0% |
| Q3 2020 | $7,334,000 | +265.8% | 75,284 | +441.8% | 0.05% | +125.0% |
| Q1 2020 | $2,005,000 | – | 13,895 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |